A
Agios Pharmaceuticals D
D
AGIO
35.180
USD
-0.21
(-0.59%)
مفتوح الان
حجم التداول
20,130
الربح لكل سهم
-6
العائد الربحي
-
P/E
3
حجم السوق
2,006,322,260
المقالات
العنوان: Agios Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.